Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Disease, Chronic Obstructive

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations

NCT01381406

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

NCT01128634

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

First Time in Human Study With GSK1325756

NCT01209052

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

NCT01453478

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Nottingham, United Kingdom

View Trial Details

Completed

QTc Study GSK573719+GW642444

NCT01521377

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.

NCT01899638

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Shanghai, China

View Trial Details

Completed

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

NCT02173769

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Boehringer Ingelheim Investigational Site 1 Aachen, Germany

Boehringer Ingelheim Investigational Site 2 Ahaus, Germany

Boehringer Ingelheim Investigational Site 3 Aichtal, Germany

Boehringer Ingelheim Investigational Site 4 Aldenhoven, Germany

View all 701 locations

View Trial Details

Completed

A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)

NCT01551758

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Altrincham, Cheshire, United Kingdom

GSK Investigational Site Altrincham, Cheshire, United Kingdom

GSK Investigational Site Altrincham, Cheshire, United Kingdom

GSK Investigational Site Altrincham, Cheshire, United Kingdom

View all 178 locations

View Trial Details

Completed

Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population

NCT01337336

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Prophylactic Efficacy of Relenza Against Influenza A and B

NCT01156701

Conditions: Asthma, Bronchial Diseases, Bronchial Spasm, +29 more
Locations: Not specified

View Trial Details